Lanoxin (digoxin) Tablets

Hazardous Ingredients

NAME CAS/EINECS/ELINCS # % GW LIMITS OTHER LIMITS w/v or w/w (mcg/m3) Digoxin 20830-75-5 (CAS) 1 mcg/m3 EEC244-088-1 (EINECS) (8 hour TWA) Not established OEL (pure substance) SECTION 3: HAZARDS IDENTIFICATION THE RISK OF HEALTH HAZARDS MAY BE REDUCED WHEN LANOXIN® TABLETS ARE HANDLED IN UNIT DOSAGE FORM. Digoxin is very toxic by inhalation and if swallowed in excess of the therapeutic dose. Digoxin is readily absorbed from the gastrointestinal tract and is rapidly distributed throughout the body. Contact with the eye can cause temporary visual disturbances. Exposure in excess of the occupational exposure limit for digoxinmay cause symptoms including: nausea, vomiting, diarrhea, abdominal pain, yellow vision, low blood pressure, and irregular pulse; massive overdose may cause heart failure. Detected in breast milk. May have adverse effect on nursing infant. See also Section 11: “Toxicological Information”. TO THE BEST OF OUR KNOWLEDGE THE INFORMATION CONTAINED HEREIN IS ACCURATE AS OF THE DATE HEREOF. ANY DETERMINATION AS TO THE SUITABILITY OF THE PRODUCT FOR ANY PARTICULAR PURPOSE, ITS SAFE USE OR DISPOSAL SHALL BE THE RESPONSIBILITY OF THE USER. THE INFORMATION CONTAINED HEREIN IS IN NO WAY INTENDED TO SUPPLEMENT, MODIFY OR SUPERSEDE THE INFORMATION PROVIDED IN THE PRODUCT PACKAGE INSERT WITH RESPECT TO THE USE OF THE PRODUCT FOR MEDICAL PURPOSES. PLEASE REFER TO THE PRODUCT PACKAGE INSERT FOR INFORMATION REGARDING THE USE OF THE PRODUCT FOR MEDICAL PURPOSES.